首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel
Authors:Ryckmans Thomas  Aubdool Aisah A  Bodkin Jennifer V  Cox Peter  Brain Susan D  Dupont Thomas  Fairman Emma  Hashizume Yoshinobu  Ishii Naoko  Kato Teruhisa  Kitching Linda  Newman Julie  Omoto Kiyoyuki  Rawson David  Strover Jade
Institution:a Pfizer Worldwide Medicinal Chemistry, Ramsgate Road, Sandwich, Kent CT139NJ, United Kingdom
b Cardiovascular Division, King’s College London, Franklin-Wilkins Building, Waterloo Campus, London SE1 9NH, United Kingdom
c Pfizer Discovery Biology, Ramsgate Road, Sandwich, Kent CT139NJ, United Kingdom
d Pfizer Global Research and Development, Nagoya Laboratories, 5-2 Taketoyo, Aichi 470-2394, Japan
Abstract:TrpA1 is an ion channel involved in nociceptive and inflammatory pain. It is implicated in the detection of chemical irritants through covalent binding to a cysteine-rich intracellular region of the protein. While performing an HTS of the Pfizer chemical collection, a class of pyrimidines emerged as a non-reactive, non-covalently binding family of agonists of the rat and human TrpA1 channel. Given the issues identified with the reference agonist Mustard Oil (MO) in screening, a new, non-covalently binding agonist was optimized and proved to be a superior agent to MO for screening purposes. Compound 16a (PF-4840154) is a potent, selective agonist of the rat and human TrpA1 channel and elicited TrpA1-mediated nocifensive behaviour in mouse.
Keywords:TrPpA1  Agonist  Pain  Nociception  HTS  TrpA1 knockout
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号